Immunization of Metastatic Breast Cancer Patients with CD80-Modified Breast Cancer Cells and GM-CSF

This publication has 16 references indexed in Scilit:

• High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.
  Journal of Clinical Oncology, 1997
• Costimulation by B7-1 and LFA-3 Targets Distinct Nuclear Factors That Bind to the Interleukin-2 Promoter: B7-1 Negatively Regulates LFA-3-Induced NF-AT DNA Binding
  Molecular and Cellular Biology, 1997
• CD28:B7 interactions promote T cell adhesion
  European Journal of Immunology, 1995
• Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
  The Journal of Experimental Medicine, 1994
• Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene
  Cellular Immunology, 1993
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
  Proceedings of the National Academy of Sciences, 1993
• Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells
  Science, 1993
• Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
  Cell, 1992
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Amplification of c-erbB-2 and Aggressive Human Breast Tumors?
  Science, 1988